Skip to main content
Michael Econs, MD, Endocrinology, Indianapolis, IN

Michael J Econs MD

Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid


Professor of Medicine, Indiana University

Join to View Full Profile
  • 1120 W Michigan StIndianapolis, IN 46202

  • Phone+1 317-274-0550

  • Fax+1 317-944-1289

Dr. Econs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1989
  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1983 - 1986
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1983

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1997 - 2027
  • NC State Medical License
    NC State Medical License 1987 - 2017
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Powerchart and Cerner Healthe, Cerner Corporation, 2013-2017
  • CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2013-2017
  • CMS Meaningful Use Stage 2 Certification FirstNet (Clinical), Cerner Corporation, 2013-2017

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Ashibio Reports Promising Preclinical Data for Two First-in-Class Antibodies Targeting Debilitating Bone Disorders at ASBMR Meeting
    Ashibio Reports Promising Preclinical Data for Two First-in-Class Antibodies Targeting Debilitating Bone Disorders at ASBMR MeetingSeptember 8th, 2025
  • SiSaf Announces Michael J. Econs MD, World-Leading Expert in Metabolic Bone Disease, as Clinical Advisor
    SiSaf Announces Michael J. Econs MD, World-Leading Expert in Metabolic Bone Disease, as Clinical AdvisorJanuary 27th, 2022
  • Study Suggests More Older Women May Benefit from Bone Drugs
    Study Suggests More Older Women May Benefit from Bone DrugsOctober 5th, 2018

Grant Support

  • Autosomal Dominant Osteopetrosis: A Natural History StudyINDIANA UNIVERSITY INDIANAPOLIS2024–2027
  • The Effects Of Iron Status On FGF23 Metabolism And Bone Health.National Institute Of Arthritis And Musculoskeletal And Skin Diseases2011–2012
  • Identification Of Genes That Affect PEAK BMD In Men And WomenNational Institute On Aging2011
  • Clinical And Genetic Analysis Of ADHRNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2011
  • Genetic Determinants Of Bone FragilityNational Institute On Aging2000–2010

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: